Eprex Injection 3,000 IU contains Erythropoietin Alfa, a recombinant human erythropoietin used to stimulate red blood cell production in patients with anemia. It is primarily indicated for anemia associated with chronic kidney disease, chemotherapy, or other medical conditions leading to reduced erythropoietin levels. By increasing red blood cell counts, Eprex Injection enhances oxygen delivery to tissues, alleviates fatigue, and improves overall quality of life.
Anemia is a condition marked by a decrease in red blood cells or hemoglobin, which can cause weakness, pallor, shortness of breath, and decreased physical performance. In patients with chronic illnesses, chemotherapy, or kidney dysfunction, the natural production of erythropoietin may be insufficient. Eprex Injection 3,000 IU effectively compensates for this deficiency, stimulating red blood cell formation and reducing the clinical symptoms of anemia.
This 3,000 IU formulation is suitable for moderate-dose therapy or for patients transitioning between low and high doses. The injection can be administered subcutaneously or intravenously, depending on clinical needs, and dosing is individualized based on patient weight, hemoglobin levels, and therapeutic response.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Active Ingredient:
Erythropoietin Alfa 3,000 IU per injection
Effective Anemia Management:
Stimulates production of red blood cells in the bone marrow
Increases hemoglobin and hematocrit levels
Reduces fatigue, weakness, and shortness of breath
Versatile Therapeutic Use:
Anemia due to chronic kidney disease (dialysis and non-dialysis patients)
Chemotherapy-induced anemia in cancer patients
Reducing the need for blood transfusions in surgical patients
Convenient Administration:
Subcutaneous or intravenous injection depending on patient requirements
Moderate-dose formulation suitable for individualized therapy
Supports monitoring and adjustment of treatment based on clinical response
Erythropoietin Alfa is a glycoprotein that mimics the naturally occurring hormone erythropoietin, produced by the kidneys. It binds to erythropoietin receptors on erythroid progenitor cells in the bone marrow, stimulating their proliferation and differentiation into mature red blood cells. This increases oxygen-carrying capacity and alleviates symptoms of anemia.
Unlike blood transfusions, Eprex promotes the body’s natural red blood cell production, reducing dependency on transfusions and associated risks such as infections or iron overload.
Eprex Injection 3,000 IU is indicated for:
Anemia associated with chronic kidney disease, including dialysis and non-dialysis patients
Chemotherapy-induced anemia in cancer patients
Reduction in the requirement for allogeneic blood transfusions in surgical patients
Other conditions causing insufficient erythropoietin production as determined by a healthcare professional
Administer subcutaneously or intravenously as directed by a physician.
Dose is individualized according to hemoglobin levels, body weight, and patient response.
Typically administered 1–3 times per week, depending on clinical needs.
Monitor hemoglobin and hematocrit regularly to prevent excessive red blood cell production.
Do not alter the dose or frequency without medical guidance, and do not discontinue therapy abruptly.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Blood pressure should be monitored, as hypertension may occur.
Inform your doctor of any history of cardiovascular disease, clotting disorders, or stroke.
Common side effects include headache, joint pain, injection site reactions, and mild hypertension.
Rare but serious events include thromboembolism, pure red cell aplasia, and severe allergic reactions. Seek immediate medical attention if these occur.
Use caution in patients with cardiovascular risk factors.
Store in a refrigerator at 2–8°C.
Do not freeze.
Protect from light and agitation.
Keep out of reach of children.
Eprex Injection 3,000 IU is a safe and effective therapy for managing anemia, stimulating red blood cell production, and improving oxygen delivery. Its moderate-strength formulation is ideal for individualized therapy under medical supervision.
Login Or Registerto submit your questions to seller
No none asked to seller yet